Get started
Author

Shakir Atoyebi

Observed names: Atoyebi, Shakir, Atoyebi, Shakir A. M., Shakir A. Atoyebi, Shakir Adeyinka Atoyebi
ORCID: 0000-0002-1393-3753
Observed ORCID: 0000-0002-1393-3753
OpenAlex ID: A5046884271
Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies
2019 · Shakir Adeyinka Atoyebi, Rajith K.R. Rajoli, et al. · European Journal of Pharmaceutical Sciences · 29
PDF
Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
2024 · Shakir Atoyebi, Fazila Bunglawala, et al. · British Journal of Clinical Pharmacology · 26
PDF
Physiologically-based pharmacokinetic modelling of infant exposure to efavirenz through breastfeeding
2018 · Adeniyi Olagunju, Rajith K. R. Rajoli, et al. · AAS Open Research · 18
Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester
2021 · Babajide Shenkoya, Shakir Atoyebi, et al. · Frontiers in Pediatrics · 12
Physiologically based pharmacokinetic modeling of drug–drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy
2024 · Shakir Atoyebi, Maiara Camotti Montanha, et al. · CPT Pharmacometrics & Systems Pharmacology · 10
PDF
Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies
2026 · Rachel K. Scott, Sharon Nachman, et al. · Clinical Pharmacology & Therapeutics · 8
The Promises and Prospects of Long-Acting Therapeutics for Treatment and Prevention of Infectious Diseases
2025 · Adeniyi Olagunju, Simone Perazzolo, et al. · The Annual Review of Pharmacology and Toxicology · 7
Comparative modelling of foetal exposure to maternal long-acting injectable versus oral daily antipsychotics
2025 · Philip Bediako-Kakari, Mariella Monyo, et al. · npj Women s Health · 5
PDF
PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing
2026 · Shakir Atoyebi, Prajith Venkatasubramanian, et al. · Clinical Pharmacology & Therapeutics · 2
PDF
Physiologically Based Pharmacokinetic Modelling of the Co-administration of Ritonavir-Boosted Atazanavir and Rifampicin in Children Co-treated for HIV and Tuberculosis
2024 · Shakir Atoyebi, Maiara Camotti Montanha, et al. · Research Square · 2
PDF
Bridging the exposure-safety gap in the assessment of fetal exposure to maternal drugs
2025 · Karolina Radziun, Ilenia D’Angelo, et al. · Expert Opinion on Drug Metabolism & Toxicology · 1
Model‐based evaluation of the interaction between ritonavir‐boosted atazanavir and rifampicin in Ugandan adults with HIV
2025 · Allan Kengo, Juan Eduardo Resendiz‐Galvan, et al. · British Journal of Clinical Pharmacology · 1
PDF
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using LC-MS/MS
2024 · Adeniyi Olagunju, Jacinta Nwogu, et al. · 1
PDF
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry
2022 · Adeniyi Olagunju, Jacinta Nwogu, et al. · Wellcome Open Research · 1
PDF
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry
2021 · Adeniyi Olagunju, Jacinta Nwogu, et al. · Wellcome Open Research · 1
PDF
Modelling the tail-phase pharmacokinetics of long-acting cabotegravir and rilpivirine from early pregnancy to postpartum at steady state
2026 · Shakir Atoyebi, Catriona Waitt, et al. · Journal of Pharmacokinetics and Pharmacodynamics
PDF
Comparative modeling of fetal exposure to maternal long-acting injectable versus oral daily antipsychotics
2024 · Philip Bediako-Kakari, Mariella Monyo, et al. · medRxiv
PA-727 Physiologically-based pharmacokinetic modelling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy
2023 · Shakir Atoyebi, Maiara Camotti Montanha, et al.
PDF
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry
2022 · Adeniyi Olagunju, Jacinta Nwogu, et al. · Wellcome Open Research
PDF
CCDC 1443327: Experimental Crystal Structure Determination
2017 · Taiwo, Bamigboye J., Osasan, Josephine Y., et al. · The Cambridge Structural Database
Works count: 23
Citation count: 124
H-index: 7
I10-index: 5
Year
Topic
Type